Loading…
SI-BONE, Inc.
SI-BONE, Inc. (SIBN) is listed on NASDAQ and classified in Medical Devices, part of the Healthcare sector. It is headquartered in Santa Clara, United States and has 376 employees. The company is worth $966.29M. Revenue was $200.93M in fiscal 2025, up 20.2% from the year before. It reported a net loss of $18.9M. The share price is within 3% of its 52-week high. 4 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Steve Cohen (Point72 Asset Management), at $12.9M. In that quarter, 1 of them opened or added to the position and 1 reduced it. Over the last 30 days, company insiders sold $1.28M of its stock on the open market and bought none. $1.17M of those sales were scheduled in advance under 10b5-1 plans.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Major managers that reported this stock in their latest 13F.
▲ +2.2% over 5Y.
today you would have $872.73▼ -12.7%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 8 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $19.72 | $14.02 | $20.99 | $13.60 | $22.21 | $29.90 | $21.50 | $20.89 | |
| P/S | 7.3x | 4.3x | 3.6x | 6.2x | 4.5x | 8.3x | 13.3x | 9.1x | 9.2x |
| P/B | 5.3x | 4.9x | 3.6x | 5.1x | 4.8x | 5.6x | 5.8x |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| CBLLCeribell, Inc. | $25.04 | — | 7.5x | 0.00% | -43.93% | $960.99M |
| IARTIntegra Lifesciences Holdings Corp | $12.33 | 72.5x | 0.9x | 0.00% | — | $958.55M |
| SPTXSeaport Therapeutics, Inc. | $17.83 | — | 2.3x | 0.00% | — | $954.45M |
| LTGOLatigo Biotherapeutics, Inc. |
| 9.7x |
| 5.7x |
| EPS | -$0.44 | -$0.75 | -$1.13 | -$1.79 | -$1.71 | -$1.50 | -$1.55 | -$2.20 |
| Profit margin | -44.29% | -9.41% | -18.49% | -31.20% | -57.57% | -62.75% | -59.54% | -57.06% | -31.51% |
| ROE | -25.69% | -10.65% | -18.51% | -25.59% | -62.31% | -42.09% | -25.80% | -60.95% | -19.35% |
Median of the years shown; P/E years above 200x are left out.
| $14.00 |
| — |
| — |
| 0.00% |
| — |
| $928.19M |
| QDELQuidelOrtho Corp | $13.48 | — | 0.5x | 0.00% | -45.91% | $924.4M |
| CSTLCastle Biosciences Inc | $33.19 | — | 2.2x | 0.00% | -4.20% | $1.01B |